Cilostazol, a selective cAMP phosphodiesterase inhibitor, dilates retinal arterioles and increases retinal and choroidal blood flow in rats

European Journal of Pharmacology

Volumn 344, Issue 1, 1998, Pages 49-52

  Hotta, Harumi ^a   Ito, Hideki ^b   Kagitani, Fusako ^a   Sato, Akio ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Blood flow; Cilostazol; Digital video microscopy; Laser Doppler flowmetry; Retinal arteriole; Vasodilation

Indexed keywords

CILOSTAZOL; CYCLIC AMP PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CHOROID VASCULARIZATION; CONTROLLED STUDY; DRUG EFFECT; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA ARTERY; VASODILATATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ARTERIOLES; CHOROID; MALE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; RETINAL VESSELS; TETRAZOLES; VASODILATOR AGENTS;

EID: 17944400903     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00015-6     Document Type: Article

References (11)

1. Adachi T., Baramidze D.G., Sato A. Stimulation of the nucleus basalis of Meynert increases cortical cerebral blood flow without influencing diameter of the pial artery in rats. Neurosci. Lett. 143:1992;173-176.
2. Alm, A., 1992. Ocular circulation. In: Hart Jr., W.M. (Ed.), Adler's Physiology of the Eye, 9th edn. Mosby, St. Louis, pp. 198-227.
3. Bard, P., 1961. Medical Physiology, 11th edn. Mosby, St. Louis.
4. Habazettl H., Conzen P.F., Vollmar B., Baier H., Christ M., Goetz A.E., Peter K., Brendel W. Dilation of coronary microvessels by adenosine induced hypotension in dogs. Int. J. Microcirc. Clin. Exp. 11:1992;51-65.
5. Kihara M., Schmelzer J.D., Low P.A. Effect of cilostazol on experimental diabetic neuropathy in the rat. Diabetologia. 38:1995;914-918.
6. Kulkarni P., Joshua I.G., Roberts A.M., Barnes G. A novel method to assess reactivities of retinal microcirculation. Microvasc. Res. 48:1994;39-49.
7. Leeson T.S. Rat retinal blood vessels. Can. J. Ophthalmol. 14:1979;21-28.
8. Nishi T., Tabusa F., Tanaka T., Shimizu T., Kanbe T., Kimura Y., Nakagawa K. Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors: II. 6-[3-(1-cyclohexyl-5-tetrazolyl)propoxy]-1,2-dihydro-2-oxoquinoline and related compounds. Chem. Pharm. Bull. 31:1983;1151-1157.
9. Shintani S., Watanabe K., Kawamura K., Mori T., Tani T., Toba Y., Sasabe H., Nakagiri N., Hongoh O., Fujita S., Aogi T., Kido Y., Umezato M., Ishikawa M., Hiyama T. General pharmacological properties of cilostazol, a new antithrombotic drug: Part II. Effect on the peripheral organs. Arzneim.-Forsch. Drug Res. 35:1985;1163-1172.
10. Tanaka T., Ishikawa T., Hagiwara M., Onoda K., Itoh H., Hidaka H. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology. 36:1988;313-320.
11. Umekawa H., Tanaka T., Kimura Y., Hidaka H. Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new inhibitor sepharose chromatography. Biochem. Pharmacol. 33:1984;3339-3344.